SCIENCE 37
Study Configurations
SCIENCE 37
Study Configurations
Science 37’s OS supports any phase of a study — including pivotal clinical trials and real-world evidence (RWE) studies — for any number of indications such as oncology, CNS, endocrinology, pediatrics, cardiology, dermatology, respiratory, infectious, and rare diseases.
Science 37’s OS supports any phase of a study — including pivotal clinical trials and real-world evidence (RWE) studies — for any number of indications such as oncology, CNS, endocrinology, pediatrics, cardiology, dermatology, respiratory, infectious, and rare diseases.
Orchestrate Hybrid and Decentralized Clinical Trials with the Science 37 Technology-First Operating System™.
Orchestrate Hybrid and Decentralized Clinical Trials with the Science 37 Technology-First Operating System™.
Therapeutic Areas.
An important aspect of drug development is having well-developed expertise in therapeutic areas.
Expertise across:
- Neuroscience & Pain
- Infectious Diseases
- Respiratory
- Hepatology & NASH
- Oncology
- Hematology
- Immunology
- Cardiometabolic
Science 37 will partner with you and use the latest advancements to help you achieve success.
Therapeutic Areas.
An important aspect of drug development is having well-developed expertise in therapeutic areas.
Expertise across:
- Neuroscience & Pain
- Infectious Diseases
- Respiratory
- Hepatology & NASH
- Oncology
- Hematology
- Immunology
- Cardiometabolic
Science 37 will partner with you and use the latest advancements to help you achieve success.
Outcome
2,000+
Enrolled in a month
5,380+
Enrolled in half of the total recruitment period
Oncology Case Study.
Science 37 was approached by a sponsor to rescue an oncology, diagnostic, pivotal trial which was struggling to recruit a large number of patients needed for blood samples and colonoscopy data.
Science 37 provided nationwide enrollment through web-based screening and remote eConsent. Then we activated our mobile phlebotomist network to provide local blood draws. Following this our team was able to make telemedicine principal investigator referrals for local gastroenterologist procedures.
The result was decentralization on a massive scale.
Outcome
2,000+
Enrolled in a month
5,380+
Enrolled in half of the total recruitment period
Oncology Case Study.
Science 37 was approached by a sponsor to rescue an oncology, diagnostic, pivotal trial which was struggling to recruit a large number of patients needed for blood samples and colonoscopy data.
Science 37 provided nationwide enrollment through web-based screening and remote eConsent. Then we activated our mobile phlebotomist network to provide local blood draws. Following this our team was able to make telemedicine principal investigator referrals for local gastroenterologist procedures.
The result was decentralization on a massive scale.
Infectious Disease Case Study
A biotech company was developing highly differentiated antibodies as part of a global, multi-center, double-blind, placebo-controlled clinical trial.
The CRO activated and managed the traditional sites start up and monitoring. The Science 37 technology platform was deployed across all sites to enable 100% patient coverage and was the system of record. This is an example of agile clinical trials in action.
Infectious Disease Case Study
A biotech company was developing highly differentiated antibodies as part of a global, multi-center, double-blind, placebo-controlled clinical trial.
The CRO activated and managed the traditional sites start up and monitoring. The Science 37 technology platform was deployed across all sites to enable 100% patient coverage and was the system of record. This is an example of agile clinical trials in action.
Hepatology Case Study
A top 10 pharma company was studying, on a global scale, the effectiveness of treatment for hepatobiliary disease, including China, Russia, Europe and the Americas.
Science 37 activated a technology platform in Russia and China. We utilized a Science 37 Metasite ™ in the US, and using our technology platform+ we were able to deploy nursing teams globally.
This is another example of agile clinical trials in action.
Hepatology Case Study
A top 10 pharma company was studying, on a global scale, the effectiveness of treatment for hepatobiliary disease, including China, Russia, Europe and the Americas.
Science 37 activated a technology platform in Russia and China. We utilized a Science 37 Metasite ™ in the US, and using our technology platform+ we were able to deploy nursing teams globally.
This is another example of agile clinical trials in action.
Learn Why our Clients Trust Us
[The Science 37] Metasite strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.
“[The Science 37] Metasite strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.”
IDC Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment, #US50382823, March 2023
Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collecte
“Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collected is accurate.”
GlobalData
Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.
“Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.”
Clinical Trial Sponsor